StageUnattributed | Alive
Last Raised$300K | 1 yr ago
About Lattice Therapeutics
Lattice Therapeutics offers a nucleic acid delivery platform. It aims to unlock gene and nucleic acid therapy's transformative potential for medicine to both cure and prevent disease by creating a non-viral, precision drug delivery platform. Lattice Therapeutics was formerly known as Hatcht. The company was founded in 2020 and is based in Washington, DC.
Missing: Lattice Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Lattice Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Lattice Therapeutics Frequently Asked Questions (FAQ)
When was Lattice Therapeutics founded?
Lattice Therapeutics was founded in 2020.
Where is Lattice Therapeutics's headquarters?
Lattice Therapeutics's headquarters is located at 4314 13th Place North East, Washington.
What is Lattice Therapeutics's latest funding round?
Lattice Therapeutics's latest funding round is Unattributed.
How much did Lattice Therapeutics raise?
Lattice Therapeutics raised a total of $300K.
Who are the investors of Lattice Therapeutics?
Investors of Lattice Therapeutics include JLabs.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.